Astellas Receives Positive CHMP Opinion for VEOZA™ (fezolinetant)

Fezolinetant is an investigational nonhormonal treatment for vasomotor symptoms (VMS) associated with menopause More than half of women ages 40 to 64 wor...

October 16, 2023 | Monday | News
MHTC and Experts Unite to Spotlight Breast Cancer Awareness

In conjunction with breast cancer awareness month, the Malaysia Healthcare Travel Council (MHTC) together with Subang Jaya Medical Centre, organised a thou...

October 16, 2023 | Monday | News
Clearside Biomedical Announces Advancement of XIPERE® in Asia-Pacific

Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the su...

October 05, 2023 | Thursday | News
Malaysia's Fight Against Cardiovascular Disease

Cardiovascular diseases (CVDs) present a substantial global health concern, and Malaysia, is not immune to this health issue. As reported by the World Heal...

October 05, 2023 | Thursday | News
Alvotech Announces Approval in Japan of AVT04 (ustekinumab), a Biosimilar to Stelara®

“We are thrilled to receive marketing approval for AVT04 in Japan, which will be Alvotech’s second marketed biosimilar,” said Robert Wess...

September 26, 2023 | Tuesday | News
NeuroSense Granted Patents in Europe, Japan, and Israel for its ALS Drug PrimeC

Patents valid through 2038 Clinical topline results from Phase 2b ALS trial expected in H2 2023 Corresponding patents have b...

September 21, 2023 | Thursday | News
BostonGene and Hokkaido University Hospital Collaborate to Develop Novel HER2 Protocols for Breast Cancer

Located in Sapporo, Japan, Hokkaido University Hospital stands as one of the most prominent medical institutions in the country. Affiliated with Hokkaido U...

September 20, 2023 | Wednesday | News
NTT and NCNP to Collaborate in Japan to Develop Brain Bio-Digital Twin Technology

News Highlights: Brain Bio-Digital Twin technology has the potential to change medical treatment practices by eliminating the need for invasive and cost...

September 15, 2023 | Friday | News
LifeSci Partners Expands Presence in Asia Pacific with Appointment of Jeff Seo

“LifeSci Partners is the leading provider of healthcare advisory services, with a strong presence in the U.S., Europe and Israel. We now have a great...

September 13, 2023 | Wednesday | News
GeneType Breakthrough for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Approved in Australia

Genetic Technologies Limited (GTG), a pioneering global leader in genomics-based tests focused on health, wellness, and the battle against serious diseases...

September 13, 2023 | Wednesday | News
Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases

The companies will collaborate to apply ShapeTX’s AAVid™ capsid discovery platform and transgene engineering technology along with Otsuka&...

September 08, 2023 | Friday | News
Bristol Myers Squibb Signs $50M Deal to Address Immune-Mediated Diseases in Asia

US-based startup Zenas BioPharma has entered into a license and collaboration agreement with Bristol Myers Squibb Company to develop and commercialise ob...

September 07, 2023 | Thursday | News
Neurophet becomes the inaugural Korean firm selected by Roche Diagnostics for the Startup Creasphere APAC Program

Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its participation in the global startup innovation program 'Startu...

September 06, 2023 | Wednesday | News
Sabin Institute Launches Global HPV Consortium in Malaysia to Prevent Cervical Cancer

“We are building a new ecosystem in global public health,” said Anuradha Gupta, President of Global Immunization at Sabin. “We aim to cre...

September 05, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close